Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. AGFA Healthcare Corp.
WARNING LETTER
•AGFA Healthcare Corp.•April 11, 2014

AGFA Healthcare Corp. – FDA Warning Letter, Apr 11, 2014

Record Details

An FDA inspection of AGF A Healthcare Corporation in Greenville, SC, from March 3 to April 11, 2014, revealed that the firm's medical devices, including the DX-D100 X-Ray machine, are adulterated under Section 501(h) of the Act due to non-conformity with Quality System (QS) regulations (21 CFR Part 820). The inspection identified significant violations, including inadequate documentation of corrective and preventive action (CAPA) activities (21 CFR 820.100(b)), with recurring problems like system polling failures and image loss remaining uncorrected. The firm also failed to timely review, evaluate, and investigate numerous complaints (21 CFR 820.198(c)), leaving hundreds open. Additionally, process control procedures for refurbishing DX-D100 x-ray machines were incomplete, lacking inspection requirements and quality review (21 CFR 820.70(a)). The DX-D110 X-ray machine and IMPAX CV Reporting were found misbranded under Section 502(t)(2) for failing to report device malfunctions likely to cause death or serious injury within 30 days, as required by 21 CFR 803.50(a)(2). While the firm's response outlined corrective actions for MDRs, FDA requested further details and status updates for CAPA, complaint handling, and refurbishment process improvements, with specific timelines for completion. Failure to promptly correct these violations could result in regulatory actions such as seizure, injunction, and civil money penalties. The firm must provide a comprehensive written response within fifteen business days detailing corrective actions and prevention plans.

Company
AGFA Healthcare Corp.
Inspection date
April 11, 2014
Product type
Devices
Office
Atlanta District Office
People
  • Ingrid A. Zambrana
  • Phil Cuscuna
View Company Profile

ID · f73c5be8-9c1c-43dc-95c1-81658354f2ad

Violation Codes9
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.100(b)21 CFR 820.198(c)21 CFR 820.70(a)21 U.S.C. 352(t)(2)21 U.S.C. 360i21 CFR 803.50(a)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore AGFA Healthcare Corp.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.